These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20201742)

  • 1. Listeriolysin O enhances cytoplasmic delivery by Her-2 targeting liposomes.
    Kullberg M; Owens JL; Mann K
    J Drug Target; 2010 May; 18(4):313-20. PubMed ID: 20201742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Her-2+ breast cancer cells with bleomycin immunoliposomes linked to LLO.
    Kullberg M; Mann K; Anchordoquy TJ
    Mol Pharm; 2012 Jul; 9(7):2000-8. PubMed ID: 22621404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutants of listeriolysin O for enhanced liposomal delivery of macromolecules.
    Walls ZF; Goodell S; Andrews CD; Mathis J; Lee KD
    J Biotechnol; 2013 Apr; 164(4):500-2. PubMed ID: 23416330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of macromolecules into cytosol using liposomes containing hemolysin from Listeria monocytogenes.
    Lee KD; Oh YK; Portnoy DA; Swanson JA
    J Biol Chem; 1996 Mar; 271(13):7249-52. PubMed ID: 8631734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene delivery to Her-2+ breast cancer cells using a two-component delivery system to achieve specificity.
    Kullberg M; McCarthy R; Anchordoquy TJ
    Nanomedicine; 2014 Aug; 10(6):1253-62. PubMed ID: 24632244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-component drug delivery system using Her-2-targeting thermosensitive liposomes.
    Kullberg M; Mann K; Owens JL
    J Drug Target; 2009 Feb; 17(2):98-107. PubMed ID: 19089689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sterol and pH interdependence in the binding, oligomerization, and pore formation of Listeriolysin O.
    Bavdek A; Gekara NO; Priselac D; Gutiérrez Aguirre I; Darji A; Chakraborty T; Macek P; Lakey JH; Weiss S; Anderluh G
    Biochemistry; 2007 Apr; 46(14):4425-37. PubMed ID: 17358050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential cytosolic delivery and presentation of antigen by listeriolysin O-liposomes to macrophages and dendritic cells.
    Stier EM; Mandal M; Lee KD
    Mol Pharm; 2005; 2(1):74-82. PubMed ID: 15804180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposome-doped nanocomposites as artificial-cell-based biosensors: detection of listeriolysin O.
    Zhao J; Jedlicka SS; Lannu JD; Bhunia AK; Rickus JL
    Biotechnol Prog; 2006; 22(1):32-7. PubMed ID: 16454489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific targeting of a pore-forming toxin (listeriolysin O) to LHRH-positive cancer cells using LHRH targeting peptide.
    Kheirandish MH; Jaliani HZ; Rahmani B; Nikukar H
    Toxicon; 2019 Jun; 164():82-86. PubMed ID: 30991063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trastuzumab-targeted gene delivery to Her2-overexpressing breast cancer cells.
    Mann K; Kullberg M
    Cancer Gene Ther; 2016 Jul; 23(7):221-8. PubMed ID: 27199219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of mitochondria to the liver in rats.
    Liu X; Khouri-Farah N; Wu CH; Wu GY
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2241-2247. PubMed ID: 32386240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced plasmid DNA delivery using anionic LPDII by listeriolysin O incorporation.
    Lorenzi GL; Lee KD
    J Gene Med; 2005 Aug; 7(8):1077-85. PubMed ID: 15776501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracytoplasmic delivery of listeriolysin O by a vaccinal strain of Bacillus anthracis induces CD8-mediated protection against Listeria monocytogenes.
    Sirard JC; Fayolle C; de Chastellier C; Mock M; Leclerc C; Berche P
    J Immunol; 1997 Nov; 159(9):4435-43. PubMed ID: 9379042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes.
    Mathew E; Hardee GE; Bennett CF; Lee KD
    Gene Ther; 2003 Jul; 10(13):1105-15. PubMed ID: 12808441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal Coencapsulation of Doxorubicin with Listeriolysin O Increases Potency via Subcellular Targeting.
    Walls ZF; Gong H; Wilson RJ
    Mol Pharm; 2016 Mar; 13(3):1185-90. PubMed ID: 26751497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and characterization of novel recombinant listeriolysin O-protamine fusion proteins for enhanced gene delivery.
    Kim NH; Provoda C; Lee KD
    Mol Pharm; 2015 Feb; 12(2):342-50. PubMed ID: 25521817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Listeriolysin O as a strong immunogenic molecule for the development of new anti-tumor vaccines.
    Sun R; Liu Y
    Hum Vaccin Immunother; 2013 May; 9(5):1058-68. PubMed ID: 23399758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced cytosolic delivery of plasmid DNA by a sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing potential.
    Saito G; Amidon GL; Lee KD
    Gene Ther; 2003 Jan; 10(1):72-83. PubMed ID: 12525839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic Activity of LLO Y406A Is Targeted to the Plasma Membrane of Cancer Urothelial Cells.
    Resnik N; Tratnjek L; Kreft ME; Kisovec M; Aden S; Bedina Zavec A; Anderluh G; Podobnik M; Veranič P
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.